These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 26300935

  • 1. Diagnostic Value of Arginase-1 and Glypican-3 in Differential Diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma and Metastatic Carcinoma of Liver.
    Geramizadeh B, Seirfar N.
    Hepat Mon; 2015 Jul; 15(7):e30336. PubMed ID: 26300935
    [Abstract] [Full Text] [Related]

  • 2. Arginase-1: a novel immunohistochemical marker of hepatocellular differentiation in fine needle aspiration cytology.
    McKnight R, Nassar A, Cohen C, Siddiqui MT.
    Cancer Cytopathol; 2012 Aug 25; 120(4):223-9. PubMed ID: 22298472
    [Abstract] [Full Text] [Related]

  • 3. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.
    Radwan NA, Ahmed NS.
    Diagn Pathol; 2012 Oct 30; 7():149. PubMed ID: 23111165
    [Abstract] [Full Text] [Related]

  • 4. [Role of arginase-1 expression in distinguishing hepatocellular carcinoma from non-hepatocellular tumors].
    Sang W, Gulinar A, Wang CH, Sheng WQ, Maiweilidan Y, Zhang W.
    Zhonghua Bing Li Xue Za Zhi; 2013 Aug 30; 42(8):538-42. PubMed ID: 24246920
    [Abstract] [Full Text] [Related]

  • 5. Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsies.
    Fujiwara M, Kwok S, Yano H, Pai RK.
    Cancer Cytopathol; 2012 Aug 25; 120(4):230-7. PubMed ID: 22434791
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Diagnostic role of glypican 3 and CD34 for differentiating hepatocellular carcinoma from nonmalignant hepatocellular lesions.
    Enan ET, El-Hawary AK, El-Tantawy DA, Abu-Hashim MM, Helal NM.
    Ann Diagn Pathol; 2013 Dec 25; 17(6):490-3. PubMed ID: 24012547
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical Study of Glypican-3 and HepPar-1 in Differentiating Hepatocellular Carcinoma from Metastatic Carcinomas in FNA of the Liver.
    Ibrahim TR, Abdel-Raouf SM.
    Pathol Oncol Res; 2015 Apr 25; 21(2):379-87. PubMed ID: 25108409
    [Abstract] [Full Text] [Related]

  • 10. The strength of cytomorphology and efficacy of immuno-cytochemistry in distinguishing hepatocellular carcinoma from its mimics on fine-needle aspiration cytology.
    Chikhale M, Toi PC, Siddaraju N, Ananthakrishnan R.
    Diagn Cytopathol; 2021 Jul 25; 49(7):864-875. PubMed ID: 33929782
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Significance of arginase-1, glypican-3, hepatocyte paraffin antigen 1 and alpha-fetoprotein in diagnosis and differential diagnosis of liver tumors].
    Li J, Wei L.
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr 25; 43(4):246-50. PubMed ID: 24915815
    [Abstract] [Full Text] [Related]

  • 13. The significance of arginase-1 expression in the diagnosis of liver cancer: A protocol for a systematic review.
    Wang X, Xu Y, Wang R, Dai N, Zhang W, Li F.
    Medicine (Baltimore); 2020 Feb 25; 99(9):e19159. PubMed ID: 32118719
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinicopathological features and differential diagnosis of hepatocellular carcinoma in extrahepatic metastases.
    Chen D, Li Z, Song Q, Qian L, Xie B, Zhu J.
    Medicine (Baltimore); 2018 Dec 25; 97(50):e13356. PubMed ID: 30557986
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Glutamine synthetase, heat shock protein-70, and glypican-3 in intrahepatic cholangiocarcinoma and tumors metastatic to liver.
    Lagana SM, Moreira RK, Remotti HE, Bao F.
    Appl Immunohistochem Mol Morphol; 2013 May 25; 21(3):254-7. PubMed ID: 22914614
    [Abstract] [Full Text] [Related]

  • 19. Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma.
    Lagana SM, Salomao M, Bao F, Moreira RK, Lefkowitch JH, Remotti HE.
    Appl Immunohistochem Mol Morphol; 2013 Mar 25; 21(2):170-6. PubMed ID: 22914605
    [Abstract] [Full Text] [Related]

  • 20. Hepatocyte differentiation markers in adenocarcinoma of the prostate: hepatocyte paraffin 1 but not arginase-1 is specifically expressed in a subset of prostatic adenocarcinoma.
    Giedl J, Büttner-Herold M, Wach S, Wullich B, Hartmann A, Agaimy A.
    Hum Pathol; 2016 Sep 25; 55():101-7. PubMed ID: 27184483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.